Alexandra Serris , Mayda Rahi , Christophe Rioux , Nadhira Fidouh , Veronique Joly , David Boutolleau
{"title":"一名艾滋病病毒感染者出现难治性抗病毒耐药 CMV 视网膜炎。","authors":"Alexandra Serris , Mayda Rahi , Christophe Rioux , Nadhira Fidouh , Veronique Joly , David Boutolleau","doi":"10.1016/j.ijid.2024.107229","DOIUrl":null,"url":null,"abstract":"<div><p>Cytomegalovirus (CMV) retinitis caused by drug-resistant viruses poses a major challenge in immunocompromised patients. We present the case of a patient living with HIV with persistently low CD4+ T cells count despite effective antiretroviral therapy, who experienced multiple episodes of CMV retinitis associated with iterative acquisition of resistance. The failure of ganciclovir and foscarnet treatments led us to implement a combined therapy of intravenous cidofovir, high-dose ganciclovir, and anti-CMV immunoglobulin as well as intravitreal injections of ganciclovir. This triple therapy was successful but resulted in significant myelotoxicity. Furthermore, the relapse of CMV retinitis and/or CMV viremia with each therapeutic de-escalation reflects the high level of immunodeficiency in our patient, despite sustained control of HIV viremia for several months. This case report highlights the need for a particular management of CMV infection in patients living with HIV who are immunological nonresponders.</p></div>","PeriodicalId":14006,"journal":{"name":"International Journal of Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":4.8000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S120197122400300X/pdfft?md5=56187641a390239490dbaa7c6372dac0&pid=1-s2.0-S120197122400300X-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Refractory anti-viral resistant CMV retinitis in an immunological nonresponder person living with HIV\",\"authors\":\"Alexandra Serris , Mayda Rahi , Christophe Rioux , Nadhira Fidouh , Veronique Joly , David Boutolleau\",\"doi\":\"10.1016/j.ijid.2024.107229\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Cytomegalovirus (CMV) retinitis caused by drug-resistant viruses poses a major challenge in immunocompromised patients. We present the case of a patient living with HIV with persistently low CD4+ T cells count despite effective antiretroviral therapy, who experienced multiple episodes of CMV retinitis associated with iterative acquisition of resistance. The failure of ganciclovir and foscarnet treatments led us to implement a combined therapy of intravenous cidofovir, high-dose ganciclovir, and anti-CMV immunoglobulin as well as intravitreal injections of ganciclovir. This triple therapy was successful but resulted in significant myelotoxicity. Furthermore, the relapse of CMV retinitis and/or CMV viremia with each therapeutic de-escalation reflects the high level of immunodeficiency in our patient, despite sustained control of HIV viremia for several months. This case report highlights the need for a particular management of CMV infection in patients living with HIV who are immunological nonresponders.</p></div>\",\"PeriodicalId\":14006,\"journal\":{\"name\":\"International Journal of Infectious Diseases\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.8000,\"publicationDate\":\"2024-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S120197122400300X/pdfft?md5=56187641a390239490dbaa7c6372dac0&pid=1-s2.0-S120197122400300X-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Infectious Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S120197122400300X\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S120197122400300X","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
摘要
耐药病毒引起的巨细胞病毒(CMV)视网膜炎是免疫功能低下患者面临的一大挑战。我们介绍了一例尽管接受了有效的抗逆转录病毒治疗,但 CD4+ T 细胞计数持续偏低的艾滋病病毒感染者的病例,该患者经历了多次与耐药性反复获得相关的 CMV 视网膜炎。更昔洛韦和氟卡尼治疗失败后,我们采用了静脉注射西多福韦、大剂量更昔洛韦和抗 CMV 免疫球蛋白以及静脉注射更昔洛韦的联合疗法。这种三联疗法取得了成功,但却导致了严重的骨髓毒性。此外,每次治疗降级后,CMV 视网膜炎和/或 CMV 病毒血症都会复发,这反映出患者的免疫缺陷程度很高,尽管 HIV 病毒血症已持续控制了几个月。本病例报告强调,对于免疫无反应的艾滋病病毒感染者,需要对 CMV 感染进行特殊处理。
Refractory anti-viral resistant CMV retinitis in an immunological nonresponder person living with HIV
Cytomegalovirus (CMV) retinitis caused by drug-resistant viruses poses a major challenge in immunocompromised patients. We present the case of a patient living with HIV with persistently low CD4+ T cells count despite effective antiretroviral therapy, who experienced multiple episodes of CMV retinitis associated with iterative acquisition of resistance. The failure of ganciclovir and foscarnet treatments led us to implement a combined therapy of intravenous cidofovir, high-dose ganciclovir, and anti-CMV immunoglobulin as well as intravitreal injections of ganciclovir. This triple therapy was successful but resulted in significant myelotoxicity. Furthermore, the relapse of CMV retinitis and/or CMV viremia with each therapeutic de-escalation reflects the high level of immunodeficiency in our patient, despite sustained control of HIV viremia for several months. This case report highlights the need for a particular management of CMV infection in patients living with HIV who are immunological nonresponders.
期刊介绍:
International Journal of Infectious Diseases (IJID)
Publisher: International Society for Infectious Diseases
Publication Frequency: Monthly
Type: Peer-reviewed, Open Access
Scope:
Publishes original clinical and laboratory-based research.
Reports clinical trials, reviews, and some case reports.
Focuses on epidemiology, clinical diagnosis, treatment, and control of infectious diseases.
Emphasizes diseases common in under-resourced countries.